Evotec SE (EVO) Net Cash Flow (2009 - 2026)
Evotec SE (EVO) reported Net Cash Flow of -$41491.2 for Q1 2026, down 119.31% on a YoY basis from $214896.0 in Q1 2025, and down 100.03% sequentially from $145.4 million in Q4 2025.
Evotec SE (EVO) Net Cash Flow (2009 - 2026) Analysis & Trends
Evotec SE (EVO) has 9 years of Net Cash Flow data on file, last reported at -$41491.2 in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 119.31% year-over-year to -$41491.2; the trailing twelve-month figure through Mar 2026 stood at $145.2 million (up 163.41% YoY), and the FY2025 full-year result was $145.3 million, up 163.4% from the prior year.
- Net Cash Flow eased to -$41491.2 in Q1 2026, from $145.4 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $145.4 million in Q4 2025 to a low of -$270.2 million in Q4 2022.
- A 5-year average of -$14.8 million and a median of -$18919.2 in 2025 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow sank 1082.02% in 2024 and surged 163.54% in 2025, its largest moves.
- Tracing EVO's Net Cash Flow over 5 years: stood at -$270.2 million in 2022, then jumped by 137.83% to $102.2 million in 2023, then slumped by 323.77% to -$228.8 million in 2024, then soared by 163.54% to $145.4 million in 2025, then plunged by 100.03% to -$41491.2 in 2026.
- Business Quant data shows EVO's Net Cash Flow at -$41491.2 in Q1 2026, $145.4 million in Q4 2025, and -$101628.3 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | -41,491.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41,491.23 |
| Mar 31, 2026 | -41,491.23 |
| Dec 31, 2025 | 145.39 Mn |
| Dec 31, 2025 | 145.39 Mn |
| Sep 30, 2025 | -101,628.30 |
| Sep 30, 2025 | -101,628.30 |
| Jun 30, 2025 | -11,413.55 |
| Jun 30, 2025 | -11,413.55 |
| Mar 31, 2025 | -18,919.19 |
| Mar 31, 2025 | -18,919.19 |
| Dec 31, 2024 | -228.80 Mn |
| Dec 31, 2024 | -228.80 Mn |
| Sep 30, 2024 | 10,428.69 |
| Sep 30, 2024 | 10,428.69 |
| Jun 30, 2024 | -216,177.64 |
| Jun 30, 2024 | -216,177.64 |
| Mar 31, 2024 | -92,291.86 |
| Mar 31, 2024 | -92,291.86 |
| Dec 31, 2023 | 102.25 Mn |
| Dec 31, 2023 | 102.25 Mn |